A newly equipped hospital is opening on the site of the former St. Vincent’s Medical Center in Greenwich Village. What was ...

Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure defibrillation lead for ...

For medically refractory vasovagal syncope (VVS) and functional bradycardia, the feasibility of off-label catheter ...

Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy ...

Johnson & Johnson MedTech announced positive three-month results from a study evaluating its investigational Omnypulse ...

PFA is a newer Afib ablation modality touted as reducing the risk of damaging nearby collateral structures, compared with ...

Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

Boston Scientific’s FARAPULSE system is showing some serious promise in zapping away persistent atrial fibrillation, ...

With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing ...

Medical device company Boston Scientific (NYSE:BSX) announced in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion ...